PL3774843T3 - Dipeptydowe pochodne piperydyny - Google Patents
Dipeptydowe pochodne piperydynyInfo
- Publication number
- PL3774843T3 PL3774843T3 PL19721812.6T PL19721812T PL3774843T3 PL 3774843 T3 PL3774843 T3 PL 3774843T3 PL 19721812 T PL19721812 T PL 19721812T PL 3774843 T3 PL3774843 T3 PL 3774843T3
- Authority
- PL
- Poland
- Prior art keywords
- dipeptide
- piperidine derivatives
- piperidine
- derivatives
- dipeptide piperidine
- Prior art date
Links
- 108010016626 Dipeptides Proteins 0.000 title 1
- 150000003053 piperidines Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/16—Central respiratory analeptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
- C07F5/02—Boron compounds
- C07F5/025—Boronic and borinic acid compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/0202—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-X-X-C(=0)-, X being an optionally substituted carbon atom or a heteroatom, e.g. beta-amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/0215—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing natural amino acids, forming a peptide bond via their side chain functional group, e.g. epsilon-Lys, gamma-Glu
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Crystallography & Structural Chemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862649752P | 2018-03-29 | 2018-03-29 | |
| PL42507718 | 2018-03-29 | ||
| PCT/IB2019/052616 WO2019186497A1 (en) | 2018-03-29 | 2019-03-29 | Dipeptide piperidine derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3774843T3 true PL3774843T3 (pl) | 2022-11-14 |
Family
ID=66397352
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL19721812.6T PL3774843T3 (pl) | 2018-03-29 | 2019-03-29 | Dipeptydowe pochodne piperydyny |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US10851099B2 (pl) |
| EP (1) | EP3774843B1 (pl) |
| AU (1) | AU2019246728A1 (pl) |
| CA (1) | CA3094939A1 (pl) |
| PL (1) | PL3774843T3 (pl) |
| TW (1) | TWI723366B (pl) |
| WO (1) | WO2019186497A1 (pl) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW202228720A (zh) | 2020-12-22 | 2022-08-01 | 波蘭商昂科艾倫迪治療法股份公司 | 精胺酸酶抑制劑及其使用方法 |
| WO2023086784A1 (en) * | 2021-11-10 | 2023-05-19 | Crititech, Inc. | Rucaparib particles and uses thereof |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU9797998A (en) | 1997-10-10 | 1999-05-03 | Trustees Of The University Of Pennsylvania, The | Compositions and methods for inhibiting arginase activity |
| US20100056480A1 (en) | 2006-11-21 | 2010-03-04 | Rijks Univesiteit Groningen | Use of arginase inhibitors in the treatment of asthma and allergic rhinitis |
| ES2729474T3 (es) | 2009-01-26 | 2019-11-04 | Univ Pennsylvania | Inhibidores de la arginasa y métodos de uso |
| ES2729936T3 (es) | 2010-04-22 | 2019-11-07 | Mars Inc | Inhibidores de arginasa y sus aplicaciones terapéuticas |
| ES2794006T3 (es) | 2010-10-26 | 2020-11-17 | Mars Inc | Inhibidores de arginasa como agentes terapéuticos |
| CA2824599C (en) | 2010-12-31 | 2020-03-10 | Corridor Pharmaceuticals, Inc. | Arginase inhibitors and methods of use thereof |
| AU2012326109A1 (en) | 2011-10-19 | 2014-05-29 | Mars, Incorporated | Inhibitors of arginase and their therapeutic applications |
| WO2013158262A1 (en) | 2012-04-18 | 2013-10-24 | Mars, Incorporated | Ring constrained analogs as arginase inhibitors |
| PL410665A1 (pl) | 2014-12-29 | 2016-07-04 | Oncoarendi Therapeutics Spółka Z Ograniczoną Odpowiedzialnością | Inhibitory arginazy oraz ich zastosowania terapeutyczne |
| CN107405404A (zh) | 2015-03-20 | 2017-11-28 | 塞米·欧尤·奥皮约 | 苏拉明和精氨酸酶抑制剂在恶性肿瘤中的用途 |
| US10143699B2 (en) | 2015-06-23 | 2018-12-04 | Calithera Biosciences, Inc. | Compositions and methods for inhibiting arginase activity |
| EP3368541B1 (en) | 2015-10-30 | 2020-05-27 | Calithera Biosciences, Inc. | Compositions and methods for inhibiting arginase activity |
| PL417066A1 (pl) * | 2016-05-04 | 2017-11-06 | Oncoarendi Therapeutics Spółka Z Ograniczoną Odpowiedzialnością | Inhibitory arginazy oraz ich zastosowania terapeutyczne |
| CN110352063A (zh) | 2016-11-08 | 2019-10-18 | 卡里塞拉生物科学股份公司 | 精氨酸酶抑制剂组合疗法 |
| ES2970715T3 (es) | 2016-12-22 | 2024-05-30 | Prec Pharmaceuticals Inc | Composiciones y métodos para inhibir la actividad de la arginasa |
| JP2020519583A (ja) | 2017-05-12 | 2020-07-02 | カリセラ バイオサイエンシズ，インコーポレイテッド | （３ｒ，４ｓ）−３−アセトアミド−４−アリル−ｎ−（ｔｅｒｔ−ブチル）ピロリジン−３−カルボキサミドの製造方法 |
| WO2018236828A2 (en) | 2017-06-19 | 2018-12-27 | The Regents Of The University Of California | TREATMENT OF DISEASE BY MODULATION OF ARGINASE 2 ACTIVITY IN REGULATORY T CELLS |
| EP3743510A1 (en) | 2018-01-28 | 2020-12-02 | Universite De Geneve | Arginase suppression for cancer treatment |
| WO2019159120A1 (en) | 2018-02-17 | 2019-08-22 | Astrazeneca Ab | Arginase inhibitors and methods of use thereof |
| EP3765006A4 (en) | 2018-03-13 | 2022-02-23 | Merck Sharp & Dohme Corp. | ARGINASE INHIBITORS AND METHODS OF USE |
-
2019
- 2019-03-29 WO PCT/IB2019/052616 patent/WO2019186497A1/en active Application Filing
- 2019-03-29 US US16/369,982 patent/US10851099B2/en active Active
- 2019-03-29 EP EP19721812.6A patent/EP3774843B1/en active Active
- 2019-03-29 TW TW108111213A patent/TWI723366B/zh active
- 2019-03-29 CA CA3094939A patent/CA3094939A1/en active Pending
- 2019-03-29 AU AU2019246728A patent/AU2019246728A1/en not_active Abandoned
- 2019-03-29 PL PL19721812.6T patent/PL3774843T3/pl unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2019186497A1 (en) | 2019-10-03 |
| TWI723366B (zh) | 2021-04-01 |
| US10851099B2 (en) | 2020-12-01 |
| CA3094939A1 (en) | 2019-10-03 |
| EP3774843B1 (en) | 2022-05-25 |
| AU2019246728A1 (en) | 2020-08-27 |
| TW201946900A (zh) | 2019-12-16 |
| EP3774843A1 (en) | 2021-02-17 |
| US20190300525A1 (en) | 2019-10-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1251902A1 (zh) | 橋連哌啶衍生物 | |
| IL292161A (en) | New methylquinazolinone derivatives | |
| IL283990A (en) | Modified oxopyridine derivatives | |
| IL270616B (en) | Nitrogen-substituted indoles | |
| IL289197A (en) | History of 2-hydroxycycloalkane-1-carbamoyl | |
| IL279938A (en) | History of spirochroman | |
| EP3421454A4 (en) | piperidine | |
| IL290964A (en) | A 2-aminoquinazolinone derivative | |
| ZA202106024B (en) | Heterocyclic derivatives | |
| IL290815A (en) | History of alpha-d-galactopyranoside | |
| HUE064831T2 (hu) | Szulfonil-amino-benzamid származékok | |
| PL3774843T3 (pl) | Dipeptydowe pochodne piperydyny | |
| ZA201804120B (en) | Novel pyrrolidine derivatives | |
| EP3445180A4 (en) | NATURAL SWEETENER | |
| ZA202007042B (en) | Triterpene amine derivatives | |
| PL3770162T3 (pl) | Pochodne dihydrochromenu | |
| SG11202006837XA (en) | Dihydroindolizinone derivative | |
| GB201919210D0 (en) | Dihydro-cyclopenta-isoquinoline derivatives | |
| GB201806948D0 (en) | Derivatives | |
| IL283273A (en) | Pharmacy practices | |
| IL276108A (en) | Crystalline forms of psoorstam | |
| AU2018902594A0 (en) | Improved sweetener | |
| EP3586838A4 (en) | AMIDDERIVAT |